CCRN - Buying Back In To Cross Country Healthcare

• In my view, the shares are reasonably priced in spite of the decent uptick in revenue and net income.
• While the capital structure has deteriorated, I think the relatively cheap stock price compensates investors for that problem.
• While I normally like to sell deep out of the money puts, I think the best course here is to simply go long the stock.

For further details see: